Search research articles
Contact Us
Filters
Showing results (361-370 of 560) with videos related to
Page
of 56
Sort By:
Biochimica Et Biophysica Acta
|
June 22, 2001
Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI
R Z Luo, H Peng, F Xu, et al.
Cancer Research
|
December 1, 1987
Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors
W P Peters, W D Henner, L B Grochow, et al.
International Journal of Cancer
|
October 15, 1994
The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin
F J Xu, C M Boyer, D S Bae, et al.
Gynecologic Oncology
|
May 29, 2007
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment
Donna Badgwell, Zhen Lu, Laurence Cole, et al.
Journal of the National Cancer Institute
|
August 5, 2011
The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells
Xiao-Feng Le, Weiqun Mao, Guangan He, et al.
Cancers
|
May 1, 2019
Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer
Jing Guo, Wei-Lei Yang, Daewoo Pak, et al.
Gynecologic Oncology
|
September 1, 1990
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer
E J Shpall, D Clarke-Pearson, J T Soper, et al.
Cancer
|
April 25, 2018
Potentially inappropriate medication use in older patients with breast and colorectal cancer
Meghan S Karuturi, Holly M Holmes, Xiudong Lei, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 1986
The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer
J M Niloff, R C Knapp, P T Lavin, et al.
Experimental Cell Research
|
August 1, 1993
Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells
Y J Lidor, F J Xu, O Martínez-Maza, et al.
Page
of 56
Search research articles
Search
Showing results (361-370 of 560) with videos related to
Sort By:
Page
of 56
Biochimica Et Biophysica Acta
|
June 22, 2001
Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI
R Z Luo, H Peng, F Xu, et al.
Cancer Research
|
December 1, 1987
Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors
W P Peters, W D Henner, L B Grochow, et al.
International Journal of Cancer
|
October 15, 1994
The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin
F J Xu, C M Boyer, D S Bae, et al.
Gynecologic Oncology
|
May 29, 2007
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment
Donna Badgwell, Zhen Lu, Laurence Cole, et al.
Journal of the National Cancer Institute
|
August 5, 2011
The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells
Xiao-Feng Le, Weiqun Mao, Guangan He, et al.
Cancers
|
May 1, 2019
Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer
Jing Guo, Wei-Lei Yang, Daewoo Pak, et al.
Gynecologic Oncology
|
September 1, 1990
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer
E J Shpall, D Clarke-Pearson, J T Soper, et al.
Cancer
|
April 25, 2018
Potentially inappropriate medication use in older patients with breast and colorectal cancer
Meghan S Karuturi, Holly M Holmes, Xiudong Lei, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 1986
The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer
J M Niloff, R C Knapp, P T Lavin, et al.
Experimental Cell Research
|
August 1, 1993
Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells
Y J Lidor, F J Xu, O Martínez-Maza, et al.
Page
of 56